{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:25:37Z","timestamp":1792016737252,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.neulet.2015.10.006","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T18:04:42Z","timestamp":1445105082000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease"],"prefix":"10.1016","volume":"609","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0073-7654","authenticated-orcid":false,"given":"Per","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik G.","family":"Almqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Ove","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2015.10.006_bib0005","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00726-014-1736-9","article-title":"Involvement of substance P and the NK-1 receptor in human pathology","volume":"46","author":"Mu\u00f1oz","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.neulet.2015.10.006_bib0010","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbr.2008.11.021","article-title":"Effects of substance P microinjections into the globus pallidus and central nucleus of amygdala on passive avoidance learning in rats","volume":"198","author":"Kertes","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2015.10.006_bib0015","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s11064-011-0511-5","article-title":"The role of substance P in the marginal division of the neostriatum in learning and memory is mediated through the neurokinin 1 receptor in rats","volume":"36","author":"Liu","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2015.10.006_bib0020","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0163-1047(05)80032-9","article-title":"Chronic administration of neurokinin SP improves maze performance in aged Rattus norvegicus","volume":"62","author":"Hasen\u00f6hrl","year":"1994","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.neulet.2015.10.006_bib0025","doi-asserted-by":"publisher","first-page":"e78036","DOI":"10.1371\/journal.pone.0078036","article-title":"Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels","volume":"8","author":"Campolongo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2015.10.006_bib0030","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1212\/WNL.37.7.1205","article-title":"Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex","volume":"37","author":"Beal","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2015.10.006_bib0035","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0306-4522(91)90199-X","article-title":"Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex","volume":"41","author":"Quigley","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.10.006_bib0040","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/BF00313833","article-title":"Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus","volume":"232","author":"Cramer","year":"1985","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2015.10.006_bib0045","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0165-5728(93)90197-7","article-title":"Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type","volume":"48","author":"Martinez","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2015.10.006_bib0050","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s007020170091","article-title":"Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients","volume":"108","author":"R\u00f6sler","year":"2001","journal-title":"J. Neural Transm."},{"issue":"Suppl. 5","key":"10.1016\/j.neulet.2015.10.006_bib0055","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S0893-133X(01)00318-9","article-title":"Hypothalamic regulation of sleep","volume":"25","author":"Salin-Pascual","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2015.10.006_bib0060","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0196-9781(02)00110-9","article-title":"Effects of orexin-A on memory processing","volume":"23","author":"Jaeger","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.neulet.2015.10.006_bib0065","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1523\/JNEUROSCI.0719-05.2005","article-title":"Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat","volume":"25","author":"Lambe","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2015.10.006_bib0070","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","article-title":"Hypocretin (orexin) loss in Alzheimer's disease","volume":"33","author":"Fronczek","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2015.10.006_bib0075","doi-asserted-by":"publisher","first-page":"e63136","DOI":"10.1371\/journal.pone.0063136","article-title":"Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease","volume":"8","author":"Schmidt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2015.10.006_bib0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/JAD-2012-111655","article-title":"Altered CSF orexin and \u03b1-synuclein levels in dementia patients","volume":"29","author":"Wennstr\u00f6m","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2015.10.006_bib0085","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1523\/JNEUROSCI.0408-14.2014","article-title":"Activation of neurotensin receptor 1 facilitates neuronal excitability and spatial learning and memory in the entorhinal cortex: beneficial actions in an Alzheimer's disease model","volume":"34","author":"Xiao","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2015.10.006_bib0090","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0006-8993(90)90372-I","article-title":"Reduction of neurotensin immunoreactivity in the amygdala in Alzheimer's disease","volume":"537","author":"Benzing","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2015.10.006_bib0095","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neulet.2015.10.006_bib0100","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.neurobiolaging.2007.07.007","article-title":"CSF cortisol in Alzheimer's disease and mild cognitive impairment","volume":"30","author":"Popp","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2015.10.006_bib0105","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neurobiolaging.2014.10.031","article-title":"Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type","volume":"36","author":"Popp","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2015.10.006_bib0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-101878","article-title":"Cerebrospinal fluid biomarkers for Alzheimer's disease: diagnostic performance in a homogeneous mono-center population","volume":"24","author":"Johansson","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neulet.2015.10.006_bib0115","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2015.10.006_bib0120","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2015.10.006_bib0125","first-page":"23","article-title":"Research criteria for subcortical vascular dementia in clinical trials","volume":"59","author":"Erkinjuntti","year":"2000","journal-title":"Neural Transm. Suppl."},{"key":"10.1016\/j.neulet.2015.10.006_bib0130","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neulet.2015.10.006_bib0135","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1073\/pnas.88.16.7247","article-title":"An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P","volume":"88","author":"Kowall","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2015.10.006_bib0140","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.neuropharm.2011.12.025","article-title":"Substance P activates ADAM9 mRNA expression and induces \u03b1-secretase-mediated amyloid precursor protein cleavage","volume":"62","author":"Marolda","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2015.10.006_bib0145","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuroscience.2004.04.024","article-title":"Effect of memantine on the levels of glial cells, neuropeptides, and peptide-degrading enzymes in rat brain regions of ibotenic acid-treated Alzheimer's disease model","volume":"126","author":"Ahmed","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.10.006_bib0150","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.neuroscience.2009.08.063","article-title":"Effects of memantine on soluble Alphabeta(25\u201335)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions","volume":"164","author":"Arif","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.10.006_bib0155","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0306-4522(91)90230-L","article-title":"Substance P-evoked release of acetylcholine from isolated spinal cord of the newborn rat","volume":"45","author":"Kobayashi","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2015.10.006_bib0160","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neulet.2014.03.020","article-title":"Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies","volume":"569","author":"Kasanuki","year":"2014","journal-title":"Neurosci. Lett."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015301695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394015301695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T13:15:51Z","timestamp":1567257351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394015301695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":32,"alternative-id":["S0304394015301695"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2015.10.006","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2015.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}